Benzophenones as xanthine oxidase inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Xanthine oxidase (XO) is a key enzyme in purine metabolism, catalyzing the final steps in uric acid formation.
• Elevated XO activity is linked to hyperuricemia and associated conditions like gout.
• Developing effective XO inhibitors is crucial for managing these health issues.

Purpose of the Study:

• To investigate the inhibitory potential of eight synthetic benzophenone derivatives against xanthine oxidase.
• To identify specific benzophenones with significant XO inhibitory activity.
• To characterize the inhibition kinetics and mechanism.

Main Methods:

• Spectrophotometric assay utilizing the absorbance of uric acid at 295 nm to measure XO activity.
• In vitro testing of eight synthetic benzophenones for their ability to inhibit XO.
• Determination of IC50 values and apparent inhibition constants (Ki).

Main Results:

• Three benzophenones exhibited notable inhibitory effects on XO.
• 2,2',4,4'-Tetrahydroxybenzophenone (6), 3,4,5,2',3',4'-hexahydroxybenzophenone (8), and 4,4'-dihydroxybenzophenone (3) showed IC50 values of 47.59, 69.40, and 82.94 microM, respectively.
• Compounds (8) and (3) displayed apparent inhibition constants (Ki) of 15.61 and 64.86 microM, respectively, with a mixed-type inhibition mechanism against xanthine.

Conclusions:

• Synthetic benzophenones, particularly compounds (6), (8), and (3), possess significant xanthine oxidase inhibitory properties.
• These findings highlight the therapeutic potential of specific benzophenone derivatives as xanthine oxidase inhibitors.
• Further research into these compounds could lead to novel treatments for conditions associated with elevated uric acid levels.